High cost of Xpert MTB/RIF ® testing per tuberculosis case diagnosed at Partners in Hope Medical Center, a public private HIV care clinic in Lilongwe,

Slides:



Advertisements
Similar presentations
ISTC Training Modules 2008 Your name Institution/organization Meeting Date.
Advertisements

Diagnosis of Smear negative pulmonary TB in high HIV settings: RESEARCH PRIORITIES Haileyesus Getahun, Stop TB, WHO. Expert consultation on TB/HIV research.
Global Consultation on the Implementation of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB M. Akhalaia, MD, Microbiologist, Reference.
` COMPARATIVE ACCURACY OF CARTRIDGE BASED NUCLEIC ACID AMPLIFICATION TEST AND SPUTUM MICROSCOPY FOR DIAGNOSIS OF PULMONARY TUBERCULOSIS IN HIV POSITIVE.
The Roadmap to Successful Xpert Implementation - 37 steps -
Improving diagnosis TB laboratory strengthening.
Implementation of Diagnostics in Resource-Limited Settings Amy Piatek Global Health Bureau, Office of Health, Infectious Diseases & Nutrition U.S. Agency.
Improving direct microscopy by overnight bleach sedimentation: a simple tool for peripheral Health Centres Maryline Bonnet 1, Laramie Gagnidze 1, Willie.
Mortality Among a Tuberculosis Outbreak Los Angeles County, 2007–2013 Brian Baker, MD Amit Chitnis, MD MPH Leslie Henry, BSN RN PHN 48th CTCA Educational.
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
World Health Organization TB Case Definitions
An Introduction to HIV Incidence Surveillance (HIS) in California California Department of Public Health Office of AIDS.
Systematic TB Screening: Philippine Experience The 9th Technical Advisory Group and National TB Program Mangers meeting for TB control in the Western Pacific.
Washington D.C., USA, July 2012www.aids2012.org The value of universal TB screening with GeneXpert MTB/RIF in pre-ART patients in Harare L. Mupfumi.
Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and Rifampin Resistance in HIV Infected & HIV uninfected Pulmonary TB suspects: ACTG.
International Standards of Tuberculosis Care Implementation by Pulmonologists in Private Practice in Jakarta E. Burhan 1, M. A. Nawas 1, D. Kusumo Sutoyo.
KEY CHANGES IN THE NEW NTBLCP GUIDELINES
Early and Improved TB case detection through the use of GeneXpert technology in Nepal.
The ninth Technical Advisory Group and National TB Managers meeting
Enhancing HIV/AIDS Surveillance in California California Department of Public Health Office of AIDS Guide for Health Care Providers.
1 Towards getting more HIV- positive infants on lifesaving treatment: assessing turn- around times for early infant diagnosis in Lesotho M Gill, HJ Hoffman,
Diagnosis of TB.
Module 10: Understanding Laboratory Data *Image courtesy of: World Lung Foundation.
Molecular methods for TB drug resistance testing: what is needed? Experience from Khayelitsha, Cape Town, South Africa Helen Cox, PhD, Burnet Institute.
Reduced treatment delays for drug-resistant TB/HIV co-infected patients with decentralised care and rapid Xpert MTB/Rif test in Khayelitsha, South Africa.
Xpert in the diagnostic algorithm of pulmonary TB in adult patients who are neither high risk for HIV, nor high risk for MDR-TB Preparations for the global.
Characteristics and Outcomes of a Population of Tuberculosis Inpatients in Lilongwe, Malawi Mina Hosseinipour, MD, MPH Clinical Director UNC Project Lilongwe,
Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.
INTERGRATING TB/HIV DATABASES INTERGRATING TB/HIV DATABASES Presenter: DR. LAMECK DIERO.
Evaluating Tuberculosis Surveillance and Action in an Urban and Rural Setting Kristine Lykens, Ph.D. In collaboration with Anita Kurian, MPH, MBBS Patrick.
Tuberculosis Research of INA-RESPOND on Drug-resistant
Determination of HIV Infection Among TB Patients in California, 2008 Darryl Kong 1, Jennifer Flood 1, Suzanne Marks 2, James Watt 1 1 California Department.
Treatment of Tuberculosis: New Case Case Studies Module 7A2 – March 2010.
Implementation of Thin Layer Agar for Mycobacterium culture in rural Kenya Médecins Sans Frontières.
Dr. Hind E. Satti Partners In Health, Lesotho March, 2008.
Japan Dr. Ismail M. Aboshama Zidan Surveillance Coordinator of NTP-Egypt Action Plan to Strengthen Laboratory Diagnostic.
PREVALENCE OF MDR-TB AMONGST PATIENTS WITH HIV AND TB CO- INFECTION SEEN AT THE DOTS CLINIC OF N.I.M.R., LAGOS, NIGERIA. Enya V.N.V, Onubogu C.C., Wahab.
Improving access to HIV testing and other basic health services in rural areas of Malawi through mobile clinics E.S. Schell, RN, PhD, FAAN; A. Bvumbwe,
Drug Resistance Pattern of Tuberculosis in India- Status Report Tuberculosis Research centre (ICMR)
Epidemiologic Studies Consortium Research CTCA meeting October 22, 2010 Lisa Pascopella, PhD, MPH California Department of Health Services.
Washington D.C., USA, July 2012www.aids2012.org Implementing Xpert ® MTB/RIF in Rural Zimbabwe Impact on diagnosis of smear-negative TB and time-
Module 8: Recording and reporting Global Laboratory Initiative – Xpert MTB/RIF Training Package.
NAAT Is it Time for a New Option in California?. Background CDC 2009 guidelines recommend NAAT for each patient with suspected TB for whom the test result.
Integration of TB and HIV Screening, Care and Treatment in Mulago Hospital, Uganda Rhoda Wanyenze, Doris Mwesigire, Henry Luzze, Violet Gwokyalya, Julius.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
Strengthening specimen referral and transport networks in resource-limited settings: a Nigerian pilot to improve diagnosis The 46 th UNION world conference.
The role of prevalence surveys in measuring the burden of TB, progress in TB control and improving early case detection Ikushi Onozaki WHO/STB/TBS Global.
L.A. County Public Health Partnering with the Private Community to Control TB Myrna Mesrobian, MD, MPH.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Yield and impact of repeated screening for tuberculosis and isoniazid preventive therapy among patients.
Early TB case detection in pre-trial detention centers (SIZOs) and prison colonies in Ukraine 46 th Union World Conference on Lung Health Cape Town, South.
GLOBAL TB PROGRAMME Systematic screening for active TB – operational manual and tool to help prioritization Wolfheze 2015 Knut Lönnroth, Global TB Programme.
TB and HIV integrated services at Martin Preuss Centre in Lilongwe, Malawi : “The Lighthouse Trust initiative” Dr Sam Phiri Executive Director Lighthouse.
Dr Justin O’Grady. Zambia is a high burden TB and high HIV setting 44,154 TB cases notified in 2010 – incidence of 462/100,000 pop Approx 48% of pulmonary.
Global Fund Grant Proposal Round 11: Tuberculosis Nathan Furukawa Gabriella Boyle Rebekah Miner Paa Kobina Forson Xiaoxue Huang Hunter Pugh Gap Analysis.
Attrition between TB / HIV testing and linkage to care in South Africa’s correctional facilities. 01 December 2015 Vincent Zishiri, Salome Charalambous,
Roundtable. Detection and treatment of TB Andrew Black.
Gap Analysis: Tuberculosis Care in Malawi Round 11 proposal to the Global Fund to Fight AIDS, Tuberculosis and Malaria Africa 3: Team Malawi Arianna, Babatunde,
Optimization of Sputum Smear for Detection of TB: A Prospective Blinded Evaluation Joy Sarojini Michael, Kalaiselvan S, Peter Daley, Lois Armstrong, Shalini.
Provider Initiated HIV Counseling and Testing Unit 2: Introduction and Rational for PIHCT.
Strengthening TB and HIV&AIDS Responses in East Central Uganda Strengthening Laboratory TB diagnostic capacity of peripheral laboratories in East Central.
TB- HIV Collaborative activities in Romania- may 2006 status
Participants 18year old+
Field Testing of OMNI-gene TB Sputum Optimizer in Malawi
Authors: Chepchieng DB1, Munyua MM2, Ngatia R2
PAEDIATRIC TUBERCULOSIS MAY STILL BE UNDER DIAGNOSED AND UNDER TREATED
PROGRESS IN GLOBAL TB CONTROL
Evidence for use of urinary LAM
Goal Objectives Expected Outcomes
Utilization of Audio visual medium for conveying sputum collection instructions for tuberculosis diagnosis Presenter: Fred ORINA.
Monitoring and Evaluation: A Review of Terms
Presentation transcript:

High cost of Xpert MTB/RIF ® testing per tuberculosis case diagnosed at Partners in Hope Medical Center, a public private HIV care clinic in Lilongwe, Malawi. Comparison with fluorescence microscopy in a well- equipped and experienced real world AFB laboratory D. Fitzgerald 1,2, P. Jansen 1, C. Chipungu 1, V. Dindi 1, J. Fielder 1, C. Pfaff 1,2 1 Partners in Hope, Lilongwe, Malawi, 2 University of California, Los Angeles, Program in Global Health, Los Angeles, United States

Background - Malawi Population 15 million HIV prevalence 12-15% TB prevalence 219/ TB patients HIV Positive - 63% Per capita health expenditure $50

Partners in Hope Medical Center Public private clinic HIV patients. TB diagnosis and treatment center AFB microscopy Culture not routinely available

Introduction of Xpert MTB/RIF ® Xpert machine donated Aug 2011 Donation of “near expiration date” cartridges - ability to increase testing of TB suspects

Introduction of Xpert MTB/RIF ® Population: All HIV(+) patients seen at Partners in Hope who were identified as TB suspects Suspicion of possibility TB by experienced clinician based on history and examination Lab: 1 Xpert test and 2 AFB smears Xpert testing - morning samples AFB smears – mixed

Objectives Describe in somewhat ideal real-world setting how to best use Xpert to improve TB case finding Percent of smear (-) sputum samples with (+) Xpert Number of smear (-) sputum samples that need to be tested to yield one (+) Xpert Cost of Xpert testing per smear (-) case detected (using AFB smear as initial test per Malawi draft Xpert guidelines)

Methods Retrospective review of the AFB laboratory records clinical data not collected only included sputum samples

Methods – smear definitions Samples - positive, negative or scanty (<10 AFB/100 HPF) 2007 guidelines – single scanty considered (-) 2012 guidelines – single scanty considered (+) Analysis was done both with single scanty considered (+) and single scanty considered (-)

Xpert Results Patients 417 (+) by Xpert 61 (14.6%) 58 had smear results No sputum was (+) smear and (-) Xpert

Xpert and sputum results 58 positive Xpert that had smear results 35 AFB (+) 60% 15 AFB scanty 26% 8 AFB (-) 14% Increased detection by 16% Increased detection rate by 65% if scanty considered (-)

Numbers of patients needed to be tested with Xpert to detect one case of TB Using protocol of AFB smear first and Xpert if smear “(-)” If scanty considered (-) – 16 patients If scanty considered (+) – 46 patients If Xpert was done on all cases, need to test 8 patients to detect one case

Cost analysis Only based on the price of the cartridge Did not include the cost of the machine, maintenance, lab staff etc.

Cost using Xpert following AFB smear Total smear (-) patients Smear (-) patients with (+) Xpert Number smear (-) patients tested by Xpert to detect one case Cost per test cartridge Cost to detect one smear negative case Scanty smears considered positive $20$920 Scanty smears considered negative $20$320

Conclusions Increased yield over microscopy alone by 16 % - 65% Depends on quality of smear microscopy and guidelines Cost per extra case if using smear as initial screen was quite high ($320-$920) Only possible to replace smear microscopy if costs come down

Caveats of study Retrospective Culture was not done to confirm (-) Xpert tests AFB reader was not always blinded to Xpert result increase number of scanty reads? Mixed patient population Some newly diagnosed ART naive, some already on ART

Acknowledgements Staff and patients at Partners in Hope Lisa Hirschhorn Risa Hoffman Support from PEPFAR/USAID Malawi for clinical operations at Partners in Hope Africa Mission Health Care Foundation